Three hundred ninety-one patients treated for non-Hodgkin's lymphoma from 1966 until 1983 were reviewed to discover a subset of 29 patients for whom whole abdominal radiation was the common modality of treatment. Seventeen patients were studied with staging laparotomy. the remainder by biopsy. Histologic characteristics revealed a diffuse-type pathology in 15 patients and a nodular-type in 14. Patients were further subselected into "favorable" (DWDLL, NPDLL, NML) and "unfavorable" (DULL, DML, DHL, DPDLL) histologies. Radical treatment for this series included 19 patients given a combined radio-chemotherapy program and 10 patients more conservatively treated with radiation alone. Follow-up for 16 living patients ranges from 2 to 16 years. Three patients developed secondary solid tumors and four patients died of intercurrent disease free from lymphoma. The possible role of whole abdominal radiation as definitive or adjunctive therapy is discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000421-198610000-00014DOI Listing

Publication Analysis

Top Keywords

patients
10
abdominal radiation
8
abdominal irradiation
4
irradiation non-hodgkin's
4
non-hodgkin's lymphomas
4
lymphomas therapeutic
4
therapeutic criteria
4
criteria three
4
three ninety-one
4
ninety-one patients
4

Similar Publications

Despite the pivotal role of cytotoxic T lymphocytes (CTLs) in anti-tumor immunity, a substantial proportion of CTL-rich hepatocellular carcinoma (HCC) patients experience early relapse or immunotherapy resistance. However, spatial immune variations impacting the heterogeneous clinical outcomes of CTL-rich HCCs remain poorly understood. Here, we compared the single-cell and spatial landscapes of 20 CTL-rich HCCs with distinct prognoses using multiplexed in situ staining and validated the prognostic value of myeloid spatial patterns in a cohort of 386 patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!